Annals and Essences of Dentistry
|
|
- Colleen Hancock
- 5 years ago
- Views:
Transcription
1 /aedj A POTENT REGIMEN FOR ORAL LICHEN PLANUS: A REVIEW 1 Tejaswi Katne 2 Anantha Venkata Srikar Muppirala 3 Rama Raju Devaraju 4 Ramlal Gantala 1 Post graduate student 2 Post graduate student 3 Professor and Head 4 Professor 1-4 Department of Oral Medicine and Radiology S.V.S Institute of Dental Sciences Telangana India ABSTRACT: Background:Oral lichen planus (OLP) is a chronic inflammatory disease that affects oral mucosa. Substantial fluctuation is seen between the patients in response to various treatments posing difficulty for the physician in management of the disease. Aim: To assess efficacy of any form of intervention used to manage oral lichen planus. Materials and methods: All the published randomised control trials from 2000 to 2016 in the management of OLP, comparing active interventions with or without placebo irrespective of age, gender were selected from Cochrane central register of controlled trials, CENTRAL, EMBASE and MEDLINE were included in the study, and SWOT analysis was performed. Results and conclusion: Thirty two randomised control trials using different drug interventions were included in this systematic review. The superiority of corticosteroids in remission of clinical signs of OLP is evident, though with few side effects. Future research with consistent parameters and newer formulations, directed towards personalised medicine are required in a quest of the potent regime to treat this condition. KEYWORDS: Lichen planus, drug therapy, topical steroids. INTRODUCTION Oral lichen planus is a chronic inflammatory T-cell mediated autoimmune disease with unclear aetiology. 1 The conception in pathogenesis of Oral lichen planus has been continuously changing from earlier era to recent times from initial concept of inflammation to immunological mediated reaction then followed by the idea of autoimmune mediated reaction to present genetic concept. Accordingly the treatment strategies have been continuously kept on changing to the present day. 2 Various treatment regimens have been tried to improve the lesions and to reduce the pain but a cure for OLP has not been found because of lack of an apparent cause and its recalcitrant nature. Purpose of the present systematic review was to evaluate the efficacy and safety of interventions in the treatment of OLP. Materials and methods All the published randomised control trials from 2000 to 2016 in the management of lichen planus comparing active interventions with or without placebo, irrespective of age, gender having symptomatic OLP and histopathological confirmation were included and selected from Cochrane central register of controlled trials CENTRAL, EMBASE, MEDLINE, Cochrane oral health trials register using key words lichen planus, oral lichen planus, randomised control trials oral lichen planus, steroids oral lichen planus, drug therapy oral lichen planus and SWOT analysis was performed. Study characteristics All the included studies in this systematic review were randomised control trials. The total number of participants included in the trials was 2073, with a mean of 65 subjects 7c per study. All the studies included were performed in a secondary care except for one (yoke 2006), which was a multi-centre study. Diagnosis of oral lichen planus was confirmed clinically and histopathologically in all except in one study (Malhotra 2008). Results and discussion A randomised cross over study on 48 subjects was done by Buajeeb (2000) to compare the efficacy of Flucinolone acetonide gel 0.1% in two base forms ( carbopol 1% and 0.5%) and Flucinolone acetonide in oral base 0.5% for 4 weeks and concluded that both drugs provided similar efficacy in the treatment but there was no statistical significance. 3 Study on 48 subjects using fluticasone propionate spray (50µg aqueous solution) and beta methasone sodium phosphate mouth rinse (0.5 mg tab in 10 ml of water) for 6 weeks with intervening washout with 0.15% benzydamine hydrochloride was carried out by Hegarty (2002) and concluded that both are effective in the management but fluticasone spray is easily accepted by the patients and recurrence is noticed in 4 subjects within the treatment period. 4 Efficacy and compliance of new lipid microspheres loaded with 0.025% of Clobetasol propionate (Formulation A) with commonly used formulation (a sort of dispersion of a lipophilic ointment in a hydrophilic phase) with the same amount of drug. (Formulation B) on 50 subjects for 2 months was evaluated by Campisi (2004) and concluded that Formulation A was effective and superior in terms of
2 symptom remission and compliance and recurrence was noticed in five patients receiving Formulation B. 5 Effectiveness of Clobetasol (0.025%) and cyclosporine (1.5%) was compared on 40 subjects by Conrotto (2006) in terms of long term remission of symptoms and cost effectiveness for 2 months and stated that Clobetasol is more effective than cyclosporine in inducing clinical improvement and gives less stable results with higher incidence of side effects in a follow up of 2 months. Cyclosporine is cost effective (five times higher than that of Clobetasol). 6 A study on 139 subjects was done by Yoke (2006) to compare the effectiveness of cyclosporine solution with triamcinolone acetonide in oral base for 8 weeks. Pain, burning sensation, area of reticulation erythema, ulceration were all worse in patients receiving cyclosporine by the end of 4 th week and concluded that topical cyclosporine is no more effective than steroid. 7 Topical tacrolimus (0.1%) was compared with triamcinolone acetonide (0.1%)in hypromellose 20% ointment by Laeijendecker(2006) on 40 subjects (20 in each group) for 6 weeks and results were in favour of topical tacrolimus(0.1%) which induced a better initial therapeutic response than triamcinolone but relapses occurred within 3-9 weeks of cessation of treatment. 8 Effectiveness of isotretinoin 0.18% with most frequently used isotretinoin 0.05% concentration was evaluated on 70 subjects for 3 months by Scardina (2006) and concluded that isotretinoin 0.18% was superior and effective in disappearance of dysplastic phenomena than 0.05%. 9 Study was conducted on 13 subjects by Thongprasom (2007) to compare the effectiveness of cyclosporine solution with triamcinolone acetonide 0.1% in orabase for 8 weeks and concluded that topical cyclosporine was not effective than triamcinolone acetonide and more side effects were noticed in patients receiving cyclosporine. 10 Efficacy of curcuminoids capsules (2000mg/day) for 7 weeks and prednisone 60mg/day for 1 st week on 33 subjects were evaluated by Chainani Wu (2007) which stated that curcuminoids at this dose were well tolerated but this study ended early for futility. 11 Efficacy of 1% pimecrolimus for 4 weeks on 12 subjects was done by Passeron (2007) and concluded that pimecrolimus seems to be effective and well tolerated treatment but with minimal side effects and relapse of the treatment was seen in 1 month follow up. 12 Forty subjects were evaluated to compare the efficacy and safety of pimecrolimus 1% cream with triamcinolone acetonide 0.1% for 2 months by Gorouhi (2007) drawing to a conclusion that both the drugs were effective in the management but with minimal side effects noticed with pimecrolimus in 2 months of follow up. 13 Effect of Clobetasol propionate with and without topical anti-fungal drug for 6 weeks on 35 subjects was carried by Lodi (2007) which stated that addition of miconazole significantly have not affected the signs and symptoms except in preventing iatrogenic candidiasis. 14 Study on 49 subjects was done to evaluate the efficacy and safety of betamethasone (5 mg) oral mini pulse therapy with triamcinolone acetonide 0.1% paste for 6 months by Malhotra (2008) and concluded that both are equally effective but response is earlier with betamethasone oral mini pulse therapy and relapse of the treatment was seen in half of the patients with more side effects. 15 In a study conducted by Radfar (2008), the effectiveness of Clobetasol (0.05%) and tacrolimus (0.1%) was evaluated. Regimen was used for 6 weeks on 30 subjects divided in 2 groups and summarized that the latter is superior and is more effective than Clobetasol. 16 Thirty two subjects were evaluated by Corrocher (2008) to compare the efficacy of tacrolimus 0.1% and Clobetasol 0.05% for 4 weeks and result was in favour of tacrolimus with low symptom scores and is more effective than Clobetasol. 17 Efficacy of Aloe Vera with placebo for 8 weeks on 54 subjects was carried out by Choonhakaran (2008) which stated that Aloe Vera is more effective than placebo and can be considered as a safe alternative treatment with no side effects. 18 Efficacy of pimecrolimus 1% cream (Elidel) with vehicle for 30 days on 20 subjects was evaluated by Volz (2008) drawing to a conclusion that pimecrolimus is more effective and no severe adverse reactions were reported in one month follow up. 19 Thirty subjects were evaluated to know the efficacy of Ignatia with placebo for 4 months by Mousavi (2009) which stated that Ignatia has beneficial effects. 20 One hundred and twenty four subjects were included in a study by Nolan (2009) to evaluate the efficacy of 0.2% hyaluronic acid and placebo for 28 days and concluded that 0.2% hyaluronic acid was effective in reducing size of the lesion and providing efficacy for up to 4 hrs after administration and can be useful addition to the treatment option for oral lichen planus. 21 Carbone (2009) conducted a randomized, doubleblind, placebo-controlled trial to compare the efficacy and safety of two different formulations of Clobetasol, in the topical management of OLP and to evaluate the remission from signs and symptoms. Thirty-five patients were divided into two groups: the first received clobetasol propionate 0.025% and the second was given clobetasol propionate 0.05%. In all, 14 of the 15 clobetasol 0.025% patients (93%) and 13 of the 15 clobetasol 0.05% patients (87%), had symptoms improvement after 2 months of therapy (P = in both groups). Also, 13 of the 15 clobetasol 0.025% patients (87%) and 11 of the 15 clobetasol 0.05% patients (73%) had clinical improvement after 2 months of therapy (P < 0.05 in both groups). No statistical differences were found in comparing the two different formulations. 22 8c
3 The efficacy of intralesional injection of 0.5ml BCG-PSN and 10mg triamcinolone acetonide was evaluated by Xiong (2009), in 56 patients for 2 weeks. The intralesional BCG-PSN injection is equally effective and can be a promising therapeutic alternative for erosive OLP, especially for those insensitive, or even resistant, to glucocorticoids. 23 Wu (2010) conducted a study on 69 subjects to evaluate short term efficacy and safety of thalidomide (1%) and dexamethasone (0.043%) for 3 weeks. In conclusion, thalidomide appears as effective as dexamethasone with recurrence seen in 3 month follow up and adverse effects at 1 year. 24 The efficacy of aloe vera was evaluated by Salazar- Sanchez (2010) in a study on 64 subjects, in comparison with placebo for 12 weeks and concluded that aloe vera improves total quality of life scores with no adverse effects. 25 In a 4 week study on 46 subjects by Mansourian (2011), compared the therapeutic effects of aloe vera mouth wash with triamcinolone acetonide (0.1%) for and concluded that aloe vera mouth wash is an effective substitute for triamcinolone acetonide. 26 Sawaarn (2011) assessed in 30 subjects, the efficacy of systemic lycopene 8mg/day against placebo for 8 weeks. The study concluded that lycopene is very effective in reducing the oxidative stress, which may have a role in the disease pathogenesis. 27 Mc Caughey (2011) conducted a study on 21 subjects to assess the efficacy of topical pimecrolimus 1% with placebo for 6 weeks. Pimecrolimus 1% was found superior to vehicle in reducing symptoms but with no side effects. 28 Fu (2012) in a study on 38 subjects evaluated the efficacy of amlexanox paste with dexamethasone paste for 7 days. Here, the topical application of amlexanox appeared as effective as dexamethasone with no serious side effects. 29 Sonthalia (2012) piloted an 8 week study on 40 subjects, to relate the efficacy of clobetasol propionate 0.05% with tacrolimus 0.1%. The results disclosed that the latter is effective and can be considered as first line of therapy with no adverse effects. 30 An 8 week study on 40 subjects was conducted by Lee (2013), to compare the efficacy between intralesional injection (0.5 ml) and mouth rinse of triamcinolone acetonide (0.4%). It concluded that efficacies of both the treatments were similar but rate of adverse effects was significantly lower for intralesional injection of triamcinolone acetonide than mouth rinse. 31 Mu guard (5ml) was found effective in reducing pain and ulceration associated with oral mucositis in comparison to saline bicarbonate, in a study by Velez (2014), conducted on 20 subjects. 32 Efficacy of topical curcumin and triamcinolone was evaluated in 50 subjects by Sied Javad Kia (2015). The 4 week study concluded that curcumin is effective because of its desirable anti-inflammatory effects and insignificant side effects. 33 Siva Raman (2016) compare the effectiveness of topical triamcinolone acetonide (0.1%), clobetasol (0.05%) and tacrolimus Orabase (0.03%) in the management. thirty subjects were included in this study which concluded that clobetasol propionate has higher efficacy when compared to triamcinolone acetonide and tacrolimus with no side effects. It was also inferred that triamcinolone acetonide 0.1% has better effects than tacrolimus 0.03%. 34 Numerous therapies have been considered. All the above included trials have used different interventions, comparisons, dosages, vehicles, time of application and different ways of measuring the common outcomes such as pain and clinical symptoms. Of the 32 included trials eleven trials compared an active intervention with placebo. Two active treatments were compared in thirteen trials and in eight studies same intervention was compared in different concentrations. Seven studies same intervention was compared at different concentrations. Twelve trials out of 32 have compared eight different active treatments with placebo. Not all the trials using steroids showed evidence that these treatments were better than placebo in reducing pain and lesional size of oral lichen planus. Studies conducted by Choonhakaran (2008) 18 and Salazar-Sanchez (2010) 25 have shown that aloe Vera gel may be associated with a reducing pain in OLP patients. Three trials of pimecrolimus have shown that it is better than placebo. Of them, the study by Volz (2008) 19 had a very short period of follow up and another study by McCaughy (2011) 28 had no post treatment follow up. Nolan (2009) 21 has shown weak evidence of trials using hyaluronic acid and Mousavi (2009) 20 using Ignatia. These both trials may be effective in reducing pain and clinical signs of OLP. Sawaarn (2011) 27 have conducted trial on lycopene which showed significant reduction in pain compared to placebo. Velez (2014) 32 saw significant reductions in MuGuard treated group despite of several limitations of the trial such as short span of study, head to head comparisons with steroids and Calcineurin inhibitors in management of OLP which makes it debatable. Six trials out of 32 have compared with different steroid treatments. Study by Campisi (2004) 5 showed microspheres while another trial by Malhotra (2008) 15 showed betamethasone to be effective in reducing pain. Study by Hegarty (2002) 4 has shown lesional surface area reduction favouring spray. However all the three trials were at high risk and no statistical difference was seen in other three studies. Seven trials out of 32 have compared steroids with Calcineurin inhibitors, each evaluating a different pair of intervention. Study by Corrocher (2008) 17 and Sonthalia (2012) 30 favoured tacrolimus in terms of pain reduction. Corrocher (2008) 17 was the only study with significant difference. Study by Laeijendecker (2006) 8 favoured Calcineurin in terms of clinical improvement. However studies conducted by Thongprasom 10, Radfar 16, Gorouhi 13, Sonthalia 30 have found no statistical difference in clinical response between steroid and Calcineurin inhibitor. Seven trials comparing two active interventions (excluding steroids and Calcineurin inhibitors) didn t show evidence that any of these interventions may be effective 9c
4 in reducing pain and clinical signs of OLP, except for two trials i.e. Buajeeb (2000) 3 and Scardina (2006) 9. Although several trials have been conducted with various medicaments, studies on personalised medicine are scarce. Future research should be focussed on identifying the defective protein and treatment is directed towards it. We are identifying the single nucleotide polymorphism (SNP) thus providing the matching medication. SNPs like rs , rs , rs6323, rs etc were identified in few cases of OLP. The efficacy of Clobetasol propionate, cyclosporine, curcumin and tretinoin drugs were evaluated against these protiens. Cyclosporine in these samples showed poor efficacy, while other were superior which is backing with the literature. Further insilico studies with phase are needed to direct management further competently. CONCLUSION OLP is an autoimmune mucocutaneous disorder, where the management is still empirical. With this systematic review, an attempt was made to establish various therapeutic modalities in OLP, taking into consideration only randomized control trials, using evidence based medicine analysis. Literature confirms the frequent use of topical corticosteroids, which remains the main stay in this condition, few indicated use of calcineurin inhibitors for treatment & symptomatic relief. The evidence of the trials suggests the superiority of corticosteroids in alleviating pain and remission of clinical signs of OLP with few side effects. Further studies on large scale, future research with consistent parameters and newer formulations, also the research directed towards personalised medicine are required in a quest of the potent regime to treat this condition. References: 1. Scully C, Eisen D, Carrozzo M. Management of oral lichen planus. Am J Clin Dermatol. 2000;1: Gupta S, Jawanda MK. Oral lichen planus: An update on etiology, pathogenesis, clinical presentation, diagnosis and management. Indian J Dermatol. 2015;60: Buajeeb W, Pobrurksa C, Kraivaphan P. Efficacy of fluocinoloneacetonide gel in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89: Hegarty MA, Hodgson AT, Lewsey DJ, Porter RS. Fluticasone propionate spray and betamethasone sodium phosphate mouth rinse: A randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol. 2002;47: Campisi G, Giandalia G, Caro VD, Liberto CD, Arico P, Giannola IL. Therapeutics a new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial. Br J Dermatol. 2004;150: Conrotto D, Carbone M, Carrozzo M, Arduino P, Broccoletti R, Pentenero M, et al. Cyclosporine vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol. 2006;154: Yoke CP, Tin BG, Kim JM, Rajaseharan A, Ahmed S, Thongprasom K, et al. A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102: Laeijendecker R, Tank B, Decker KS, Neumann MAH. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol. 2006;86: Scardina GA, Messina P, Carini F, Maresi E. A randomized trial assessing the effectiveness of different concentrations of isotretinoin in the management of lichen planus. Int J Oral Maxillofac Surg. 2006;35: Thongprasom K, Chaimusig M, Korkij W, Sererat T, Luangjarmekorn L, Rojwattanasirive S. A randomizedcontrolled trial to compare topical cyclosporine with triamcinolone acetonide for the treatment of oral lichen planus. J Oral Pathol Med. 2007;36: Chainani-Wu N, Silverman S, Reingoldb A, Bostromc A, Mc Cullochc C, Lozada- Nura F, et al. A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine. 2007;14: Passeron T, Lacour PJ, Fontas E, Ortonne PJ. Treatment of Oral erosive lichen planus with 1% pimecrolimus cream. A double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol. 2007;143(4): Gorouhi F, Solhpour A, Beitollahi JM, Afshar S, Davari P, Hashemi P, et al. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. J Am Acad Dermatol. 2007;57: Lodi G, Tarozzi M, Sardella A, Demarosi F, Canegallo L, Di Benedetto D, et al. Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. Br J Dermatol. 2007;156: Malhotra AK, Khaitan BK, Sethuraman G, Sharma VK. Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative study. J Am Acad Dermatol. 2008;58: Radfar L, Wild CR, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105: Corrocher G, Lorenzo DG, Martinelli N, Mansueto P, Biasi D, Nocini FP, et al. Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. J Clin Periodontol. 2008;35: Choonhakaran C, Busaracome P, Sripanidkulchai B, Sarakarn P. The efficacy of aloe Vera gel in the treatment of oral lichen planus: a randomized controlled trial. Br J Dermatol. 2008;158: Volz T, Caroli U, Ludtke H, Brautigam M, Kohler- Spath H, Rocken M, et al. Pimecrolimus cream 1% in erosive oral lichen planus- a prospective randomiz ed double-blind vehicle-controlled study. Br J Dermatol. 2008;159: c
5 20. Mousavi F, Sherafati S, Mojaver YN. Ignatia in the treatment of oral lichen planus. Homeopathy. 2009;98: Nolan A, Badminton J, Maguire J, Seymour AR. The efficacy of topical hyaluronic acid in the management of oral lichen planus. J Oral Pathol Med. 2009;38: Carbone M, Arduino GP, Carrozzo M, Caiazzo G, Broccoletti R, Conrotto D, et al. Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J Oral Pathol Med. 2009;38: Xiong C, Li Q, Lin M, Li X, Meng W, Wu Y, et al. The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial. J Oral Pathol Med. 2009;38: Wu Y, Zhou G, Zeng H, Xiong C, Lin M, Zhou H, et al. A randomized double-blind, positive-control trial of topical thalidomide in erosive oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110: Salazar-Sanchez N, Lopez-Jornet P, Camacho- Alonso F, Sanchez-Siles M. Efficacy of topical Aloe Vera in patients with oral lichen planus: a randomized double-blind study. J Oral Pathol Med. 2010;39: Mansourian A, Momen-Heravi F, Saheb-Jamee M, Esfehani M, Khalilzadeh O, Momen-Beitollahi J. Comparison of Aloe vera mouthwash with triamcinolone acetonide 0.1% on oral lichen planus: a randomized double-blinded clinical trial. Am J Med Sci. 2011;342(6): Sawaarn N, Shashikanth MC, Sawaarn S, Jirge V, Chaitanya CSKN, Pinakapani R. Lycopene in the management of oral lichen planus: A placebo controlled study. IJDR. 2011;22(5): McCaughey C, Machan M, Bennett R, Zone JJ, Hull CM. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehiclecontrolled study with a 6-week open-label extension to assess efficacy and safety. J Eur Acad Dermatol Venereol. 2011;25: Fu J, Zhu X, Dan H, Zhou Y, Liu C, Wang F, et al. Amlexanox is as effective as dexamethasone in topical treatment of erosive oral lichen planus: a shortterm pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2012;113: Sonthalia S, Singal A. Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial. Int J Dermatol. 2012;51: Lee YC, Shin SY, Kim SW, Eun YG. Intralesional injection versus mouth rinse of triamcinolone acetonide in oral lichen planus: a randomized controlled study. Otolaryngol Head Neck Surg. 2013;148: Velez I, Spielholz NI, Siegel MA, Gonzalez T, MuGuard, an oral muco adhesive hydrogel, reduces the signs and symptoms of oral mucositis in patients with lichen planus: a double-blind, randomized, placebo-controlled pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118: Kia SJ, Shirazian S, Mansourian A, Khodadadi FL, Ashnagar S. Comparative Efficacy of Topical Curcumin and Triamcinolone for Oral Lichen Planus: A Randomized, Controlled Clinical Trial. J Dent (Tehran). 2015;12(11): Siva Raman S, Santham K, Nelson A, Laliytha B, Azhalvel P, Deepak JH. A randomized triple-blind clinical trial to compare the effectiveness of topical triamcinolone acetonate (0.1%), clobetasol propionate (0.05%), and tacrolimus Orabase (0.03%) in the management of oral lichen planus. J Pharm Bio all Sci. 2016;8:S86-9. Corresponding Author Dr. Tejaswi Katne Post Graduate student Department of Oral Medicine and Radiology S.V.S Institute of Dental sciences Telangana, India Ph No Id: tejaswikatne@gmail.com 11c
DOI /j x
THERAPEUTICS DOI 10.1111/j.1365-2133.2007.07883.x Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial G. Lodi, M. Tarozzi, A. Sardella, F. Demarosi, L. Canegallo,
More informationComparison of Two Corticosteroids Mouthwashes in Treatment of Symptomatic Oral Lichen Planus
Ahadian H., et al J Dent Shiraz Univ Med Scien. 212 June; 13(2): 49-53 Original Article Comparison of Two Corticosteroids Mouthwashes in Treatment of Symptomatic Oral Lichen Planus Ahadian H. a, Akhavan
More informationComparative Efficacy of Topical Curcumin and Triamcinolone for Oral Lichen Planus: A Randomized, Controlled Clinical Trial
Original Article Comparative Efficacy of Topical Curcumin and Triamcinolone for Oral Lichen Planus: A Randomized, Controlled Clinical Trial Seid Javad Kia 1, Shiva Shirazian 2, Arash Mansourian 3, Leila
More informationJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL SCIENCES
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL SCIENCES Sinha Abhishek, Srivastava Sunita, Mishra Anuj, Agarwal Nitin & Sinha M Pooja. Aloevera vs topical steroid in treatment of erosive lichen planus. Journal
More informationDOI /j x
THERAPEUTICS DOI 10.1111/j.1365-2133.2007.08370.x The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial C. Choonhakarn, P. Busaracome, B. Sripanidkulchai*
More informationSetting The setting was tertiary care. The economic study was carried out in Turin, Italy.
Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial Conrotto D, Carbone M, Carrozzo M, Arduino P, Broccoletti R,
More informationThe Efficacy of Aloe vera Gel in Treatment of Oral Lichen Planus
International Dental & Medical Journal of Advanced Research (2018), 4, 1 6 ORIGINAL ARTICLE The Efficacy of Aloe vera Gel in Treatment of Oral Lichen Planus Sofia Sid Ahmed 1, Laila M. Gadalla 2, Samah
More informationInternational Journal of Pharma and Bio Sciences
Original Research Article Pharmacology International Journal of Pharma and Bio Sciences ISSN 0975-6299 USE OF ALOE VERA IN THE TREATMENT OF ORAL LICHEN PLANUS-A SYSTEMATIC REVIEW RAMYA CHELLAMMAL MUTHUSAMY*
More informationSTUDY. Treatment of Oral Erosive Lichen Planus With 1% Pimecrolimus Cream
STUDY Treatment of Oral Erosive Lichen Planus With Cream A Double-blind, Randomized, Prospective Trial With Measurement of Pimecrolimus Levels in the Blood Thierry Passeron, MD; Jean-Philippe Lacour, MD;
More informationTopical Application of Drugs Used in Treatment of Oral Lichen Planus Lesions
reviews Adv Clin Exp Med 2013, 22, 6, 00 00 ISSN 1899 5276 Copyright by Wroclaw Medical University Małgorzata Radwan-Oczko Topical Application of Drugs Used in Treatment of Oral Lichen Planus Lesions Miejscowe
More informationInternational Journal of Pharma and Bio Sciences LOCAL DRUG DELIVERY IN THE TREATMENT OF ORAL LICHEN PLANUS: A SYSTEMATIC REVIEW ABSTRACT
Review Article Novel drug delivery system International Journal of Pharma and Bio Sciences ISSN 0975-6299 LOCAL DRUG DELIVERY IN THE TREATMENT OF ORAL LICHEN PLANUS: A SYSTEMATIC REVIEW SHOVNA SHIVANI
More informationWorld Journal of Pharmaceutical and Life Sciences WJPLS
wjpls, 2016, Vol. 2, Issue 5, 183-198. Research Article ISSN 2454-2229 WJPLS www.wjpls.org SJIF Impact Factor: 3.347 EVALUATION OF EFFICACY OF TACROLIMUS AND TRIAMCINOLONE ACETONIDE OINTMENT IN THE MANAGEMENT
More informationFOR HKMA CME MEMBER USE ONLY. DO NOT REPRODUCE OR DISTRIBUTE
Oral Lichen Planus Justin Au, DMD, MD*, Dhaval Patel, DDS, John H. Campbell, DDS, MS KEYWORDS Lichen planus Oral Autoimmune disease Reticular Erosive KEY POINTS Lichen planus is an immunologically mediated
More informationAvailable online at International Journal of Current Research Vol. 9, Issue, 05, pp , May, 2017
z Available online at http://www.journalcra.com International Journal of Current Research Vol. 9, Issue, 05, pp.50536-50542, May, 2017 INTERNATIONAL JOURNAL OF CURRENT RESEARCH ISSN: 0975-833X RESEARCH
More informationPACIFIC JOURNAL OF MEDICAL SCIENCES {Formerly: Medical Sciences Bulletin} ISSN:
PACIFIC JOURNAL OF MEDICAL SCIENCES {Formerly: Medical Sciences Bulletin} ISSN: 2072 1625 Pac. J. Med. Sci. (PJMS) www.pacjmedsci.com. Email: pacjmedsci@gmail.com. EROSIVE LICHEN PLANUS A CASE REPORT *Prathima
More informationPatient reported outcomes in chronic skin diseases: ehealth applications for clinical practice van Cranenburgh, O.D.
UvA-DARE (Digital Academic Repository) Patient reported outcomes in chronic skin diseases: ehealth applications for clinical practice van Cranenburgh, O.D. Link to publication Citation for published version
More informationSuccessful treatment of Oral Lichen Planus (OLP) with 0.1% topical Tacrolimus in a patient with impaired liver enzymes: A Case report
American Journal of Advances in Medical Science www.arnaca.com Vol-2: No-1: 7-11:2014 Case Report Successful treatment of Oral Lichen Planus (OLP) with 0.1% topical Tacrolimus in a patient with impaired
More informationThe efficacy of topical hyaluronic acid in the management of oral lichen planus
dol, I. I I 11/j.16-71H8.7J9.x J Oral P;athol Med (29) 18: 299-33 29 John W Iiey & Sons AJS AU rlghu reserved lnten:clence,wlley,com/jour nal//op The efficacy of topical hyaluronic acid in the management
More informationA Comparative Evaluation of Low-Level Laser and Topical Steroid Therapies for the Treatment of Erosive-Atrophic Lichen Planus
ID Design 2012/DOOEL Skopje Open Access Macedonian Journal of Medical Sciences. 2015 Sep 15; 3(3):462-466. http://dx.doi.org/10.3889/oamjms.2015.072 eissn: 1857-9655 Stomatology A Comparative Evaluation
More informationTreatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution
Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution Miguel Angel Gonzalez-Moles, MD, PhD, a Patricia Morales, DDS, PhD, b Alberto Rodriguez- Archilla, DDS, PhD,
More informationVesicular lesion of gingiva diagnosed as bullous lichen planus: Management with combination therapy
Goel et al. 1 CASE REPORT PEER REVIEWED OPEN ACCESS Vesicular lesion of gingiva diagnosed as bullous lichen planus: Management with combination therapy Khushboo Goel, Ashish Shrestha, Vinay Marla, Iccha
More informationW J S. World Journal of Stomatology. Oral lichenplanus: Etiology, pathogenesis, diagnosis, and management INTRODUCTION. Abstract MINIREVIEWS
W J S World Journal of Stomatology Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5321/wjs.v4.i1.12 World J Stomatol 2015 February 20; 4(1):
More informationScoring systems for Oral Lichen Planus used by differently experienced raters
Journal section: Oral Medicine and Pathology Publication Types: Research doi:10.4317/medoral.21833 http://dx.doi.org/doi:10.4317/medoral.21833 used by differently experienced raters Margherita Gobbo 1,
More informationA New Approach for Treatment and Prevention of Recurrent Oral Lichen Planus: A Technical Report
Series A New Approach for Treatment and Prevention of Recurrent Oral Lichen Planus: A Technical Report F. Agha-Hosseini 1, M-S. Moosavi 2, R. Varshochian 3, Kh. Akbari 4. 1 Professor, Dental Research Center,
More informationEarly View Article: Online published version of an accepted article before publication in the final form.
: Online published version of an accepted article before publication in the final form. Journal Name: Journal of Case Reports and Images in Dentistry Type of Article: Case Report Title: Vesicular lesion
More informationEfficacy of IMOD in the treatment of oral lichen planus
Open Journal of Stomatology, 2011, 1, 13-17 doi:10.4236/ojst 12003 Published Online June 2011 (http://www.scirp.org/journal//). Efficacy of IMOD in the treatment of oral lichen planus Efficacy of IMOD
More informationJournal of. Gastroenterology and Hepatology Research
Journal of Gastroenterology and Hepatology Research Online Submissions: http://www.ghrnet.org/index./joghr/ doi:10.6051/j.issn.2224-3992.2013.02.178 Journal of GHR 2013 April 21 2(4): 503-507 ISSN 2224-3992
More informationOriginal Article Oral lichen planus treated with tacrolimus 0.1%
Int J Clin Exp Med 2013;6(10):917-921 www.ijcem.com /ISSN:1940-5901/IJCEM1309016 Original Article Oral lichen planus treated with tacrolimus 0.1% João Paulo Marinho Resende 1, Maria das Graças Afonso Miranda
More informationChildhood Oral Lichen Planus: Report of Two Cases
Case Report Sageena George 1, Sheen Ann John 2, Anandaraj S 3, Jyoti Sumi Issac 4, Anoop Harris 5, Reshmi J 6 1 Professor, Department of Pedodontics and Preventive Dentistry, PMS College of Dental Science
More informationROLE OF HOMEOPATHY MEDICINE IN TREATMENT OF APTHOUS ULCER: A RANDOMIZED STUDY
Sharma B. Apthous ulcer treatment with homeopathy Doi:10.21276/ledent.18.02.02.05 Original Article ROLE OF HOMEOPATHY MEDICINE IN TREATMENT OF APTHOUS ULCER: A RANDOMIZED STUDY Bhasker Sharma1 1 M.D. (Homoeopathy),
More informationTreatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B A pilot prospective study
The Saudi Dental Journal (2012) 24, 143 148 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com ORIGINAL ARTICLE Treatment of symptomatic oral lichen planus (OLP) with 0.1%
More informationMANAGEMENT OF LICHEN PLANUS-REPORT OF 5 CASES. Aim: To evaluate the effectiveness of steroids,hydroxychloroquine sulphate,levamisole in 5 patients.
Dental Case Report International Journal of Clinical And Diagnostic Research ISSN 2395-3403 Volume 4, Issue 5, Sep-Oct 2016. Glorigin Lifesciences Private Limited. MANAGEMENT OF LICHEN PLANUS-REPORT OF
More informationNews in erosive lichen planus of the vulva
News in erosive lichen planus of the vulva Anne Lise Helgesen Dermatologist, Postdoc, National Centre of Womens Health, Oslo University Hospital, Oslo, Norway - a great challenge WHY? No evidence based
More informationOral Lichen Planus: Clinical Features, Etiology, Treatment and Management; A Review of Literature
Journal of Dental Research, Dental Clinics, Dental Prospects Review Oral Lichen Planus: Clinical Features, Etiology, Treatment and Management; A Review of Literature Marzieh Boorghani 1 Narges Gholizadeh
More informationJMSCR Vol 05 Issue 10 Page October 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i10.125 Histomorphological Study of Lichen Planus
More informationTherapeutic Management of Oral Lichen Planus: A Review for the Clinicians
10.5005/jp-journals-10015-1091 REVIEW ARTICLE WJD Therapeutic Management of Oral Lichen Planus: A Review for the Clinicians 1 Raghavendra Kini, 2 DV Nagaratna, 3 Ankit Saha 1 Professor, Department of Oral
More informationA New Approach to the Pharmacological Treatment. of Oral Lichen Planus: Case Report
Case Report 57 Copyright University of Medicine, Tirana AJMHS Vol. 47 (2/3): 57-65 2016 A New Approach to the Pharmacological Treatment of Oral Lichen Planus: Case Report Besian Abazi 1, Joana Mihani 2
More informationWorld Workshop on Oral Medicine VI: Patient-reported outcome. measures and oral mucosal disease: current status and future direction.
1 World Workshop on Oral Medicine VI: Patient-reported outcome measures and oral mucosal disease: current status and future direction. Rícheal Ní Ríordáin, BDS, MBBS, PhD, Penelope Shirlaw BDS FDSRCPS,
More informationRevisiting and old friend - pimecrolimus
Revisiting and old friend - pimecrolimus K. A. Papp MD, PhD Probity Medical Research KAP is a consultant, investigator, speaker and advisory board member for Astellas GSK Leo Valeant 2 Warning some content
More informationEfficacy And Safety of Sauropus Androgynous in the Treatment of Aphthous Stomatitis- A Placebo Controlled Double Blind Trial
www.jmscr.igmpublication.org Impact Factor-1.1147 ISSN (e)-2347-176x Efficacy And Safety of Sauropus Androgynous in the Treatment of Aphthous Stomatitis- A Placebo Controlled Double Blind Trial Authors
More informationAmerican Journal of Cancer Science
American Journal of Cancer Science http://ivyunion.org/index.php/ajcs/ Akerzoul N et al. American Journals of Cancer Science 2015, 5:63-77 Page 1 of 6 Case Report Malignant Transformation of Erosive Oral
More informationManagement of Pyoderma Gangrenosum Mentoring in IBD XVII
Management of Pyoderma Gangrenosum Mentoring in IBD XVII Scott Walsh MD PhD FRCPC Division of Dermatology Sunnybrook Health Sciences Centre University of Toronto Pyoderma Gangrenosum: A pathological
More informationMedication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017
More informationPharmacologic Treatment of Atopic Dermatitis
J KMA Pharmacotherapeutics Pharmacologic Treatment of Atopic Dermatitis Chun Wook Park, MD Department of Dermatology, Hallym University College of Medicine E mail : dermap@paran.com J Korean Med Assoc
More information5. Undergraduate Student, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran
Original Study COMPARATIVE EVALUATION OF TWO FORMS OF DRUGS: PATCH & LOTION OF CLOBETASOL, ON RECOVERY INDICATORS OF APHTHOUS STOMATITIS Mojtahedi N, 1 Ghalayani P, 2 Golestannejad Z, 3 Davari A, 4 Shahi
More informationROLE OF ORAL HYGIENE IN THE IMMUNO-GENETIC COMPONENT OF THE PATHOGENESIS OF ORAL LICHEN PLANUS
Prophylaxis ROLE OF ORAL HYGIENE IN THE IMMUNO-GENETIC COMPONENT OF THE PATHOGENESIS OF ORAL LICHEN PLANUS Marina ANTONENKO 1, Alina PARYI 2, Natalia ZELINSKAYA 3, Serhiy PALAMARCHUK 3, Diana MAYBORODINA
More informationSmoking Habits Among Patients Diagnosed with Oral Lichen Planus
TOBACCO INDUCED DISEASES Vol. 2, No. 2: 103-108 (2004) PTID Society Smoking Habits Among Patients Diagnosed with Oral Lichen Planus Meir Gorsky, 1 Joel B. Epstein, 2 Haya Hasson-Kanfi, 1 Eliezer Kaufman
More informationAn Efficacy Study of 3 Commercially Available Hydroquinone 4% Treatments for Melasma
An Efficacy Study of 3 Commercially Available Hydroquinone 4% Treatments for Melasma Pearl E. Grimes, MD Melasma is a common disorder of hyperpigmentation typically characterized by relatively symmetric
More informationA retrospective clinicopathological study on oral lichen planus and malignant transformation: Analysis of 518 cases
Journal section: Oral Medicine and Pathology Publication Types: Research doi:10.4317/medoral.17778 http://dx.doi.org/doi:10.4317/medoral.17778 A retrospective clinicopathological study on oral lichen planus
More informationConflicts of interest
Vulvar Cases 2 nd PANHELLANIC CONGRESS on Lower Genital Tract Disorders December 14-16 Grand Hyatt Athens Lynette J. Margesson MD FRCPC Assistant Professor of Obstetrics & Gynecology and Surgery(Dermatology)
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2116-3 Program Prior Authorization/Medical Necessity Medications Dupixent (dupilumab) P&T Approval Date 1/2017, 5/2017, 7/2017
More informationCENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August
BRAND NAME Dupixent GENERIC NAME dupilumab MANUFACTURER Regeneron DATE OF APPROVAL March 28, 2017 PRODUCT LAUNCH DATE First week of April 2017 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review
More informationRELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN
RELEVANT DISCLOSURES MANAGING ECZEMA IN INFANTS AND CHILDREN Advisory board member - MEDA (Elidel), Speaking honoraria Bayer (Advantan) Advisory board, consultant, speaker: Pfizer, Abbvie, Janssen, Elli
More informationDemographic, Clinical Profile of Oral Lichen Planus and its Possible Correlation with Thyroid Disorders: A Case-Control Study
Original Article DOI: 10.17354/ijss/2015/500 Demographic, Clinical Profile of Oral Lichen Planus and its Possible Correlation with Thyroid Disorders: A Case-Control Study Mohsin Muzaffar Tak 1, Altaf Hussain
More informationOral Lichen Planus: A Retrospective Comparative Study between Thai and Croatian Patients
2 CLINICAL ARTICLE Oral Lichen Planus: A Retrospective Comparative Study between Thai and Croatian Patients Kobkan Thongprasom 1, Marinka Mravak-Stipetić 2, Pimporn Luckprom 3, Ivana Canjuga 2, Dolores
More informationDental Research Journal
Dental Research Journal Original Article Evaluation of the therapeutic effects of Aloe vera gel on minor recurrent aphthous stomatitis Neda Babaee 1,2, Ebrahim Zabihi 1,3,4, Saman Mohseni 1,2, Ali Akbar
More informationA systematic review of topical immunomodulators for management of oral mucosal conditions. Part II: miscellaneous agents
1. Background 2. Medical need 3. Existing treatment 4. Current research goals 5. Scientific rationale 6. Competitive environment 7. Potential developmental issues 8. Conclusion 9. Expert opinion Review
More information12: Ear, nose, and oropharynx
Original Date of issue: 30/03/2006 Last eviewed: 01/05/2011 Version:2 Page 1 of 5 12: Ear, nose, and oropharynx 12.1 Drugs acting on the ear 12.1.1 Otitis externa Astringent preparations Aluminium Acetate
More informationDupixent (dupilumab)
Dupixent (dupilumab) Line(s) of Business: HMO; PPO; QUEST Integration Effective Date: TBD POLICY A. INDICATIONS The indications below including FDA-approved indications and compendial uses are considered
More informationClinical behaviour of malignant transforming oral lichen planus
EJSO 2002; 28: 838±843 doi:10.1053/ejso.2002.1302, available online at http://www.idealibrary.com on 1 Clinical behaviour of malignant transforming oral lichen planus M. D. Mignogna*, L. Lo Russo*, S.
More informationNew Medicine Report. Pimecrolimus. RED- Hospital only Date of Last Revision 6 th March 2003
New Medicine Report Document Status Pimecrolimus Reviewed by Suffolk D&T RED- Hospital only Date of Last Revision 6 th March 2003 Approved Name Pimecrolimus Trade Name Elidel Manufacturer Novartis Legal
More informationClearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera?
DOI: 10.1111/jdv.14516 JEADV SHORT REPORT Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera? A. Borghi,* A. Virgili, S. Minghetti, G. Toni, M. Corazza Dipartimento di Scienze
More informationManagement of pain in oral lichen planus patients: a comparative pilot study
El Shenawy et al. Bulletin of the National Research Centre (2018) 42:15 https://doi.org/10.1186/s42269-018-0014-5 Bulletin of the National Research Centre RESEARCH Open Access Management of pain in oral
More informationThe safety and effectiveness of Dupixent in pediatric patients have not been established (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.30 Subject: Dupixent Page: 1 of 6 Last Review Date: September 15, 2017 Dupixent Description Dupixent
More informationStudy selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were eligible for inclusion in the review.
Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses Stokman M A, Spijkervet F K, Boezen H M, Schouten J P, Roodenburg J L, de Vries
More informationTopical Immunomodulator Step Therapy Program
Topical Immunomodulator Step Therapy Program Policy Number: 5.01.557 Last Review: 8/2017 Origination: 7/2013 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) BCBSKC will provide
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.25 Subject: Eucrisa Page: 1 of 6 Last Review Date: September 15, 2017 Eucrisa Description Eucrisa
More informationEFFICACY AND SAFETY OF CLOBETASOL PROPIONATE SHAMPOO IN THERAPY OF PSORIASIS OF THE SCALP
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Platonova et al. SJIF Impact Factor 2.786 Volume 4, Issue 04, 238-246. Research Article ISSN 2278 4357 EFFICACY AND SAFETY OF CLOBETASOL PROPIONATE
More informationTriamcinolone and vitiligo
P ford residence southampton, ny Triamcinolone and vitiligo Dermatologica. 1970;140(3):195-206. Treatment of localized vitiligo with intradermal injections of triamcinolone acetonide. Kandil E. PMID: 5414362;
More informationCase Report Glossodynia from Candida-Associated Lesions, Burning Mouth Syndrome, or Mixed Causespme_
Pain Medicine 2010; 11: 856 860 Wiley Periodicals, Inc. PAIN & AGING SECTION Case Report Glossodynia from Candida-Associated Lesions, Burning Mouth Syndrome, or Mixed Causespme_861 856..860 Haruhiko Terai,
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Eucrisa Page: 1 of 7 Last Review Date: June 22, 2018 Eucrisa Description Eucrisa (crisaborole)
More informationAtopic Dermatitis and Topical Antipsoriatics
Atopic Dermatitis and Topical Antipsoriatics Goal(s): Restrict dermatological drugs only for funded OHP diagnoses. Moderate/severe psoriasis and moderate/severe atopic dermatitis treatments are funded
More informationInternational Journal of Scientific Research and Innovative Technology ISSN: Vol. 4 No. 12; December 2017
THE FREQUENCY OF ORAL LICHEN PLANUS IN SAMPLES SENT TO PATHOLOGY DEPARTMENT OF TABRIZ DENTAL SCHOOL (2006-2016) AND ITS RELATION WITH AGE, SEX, LESION TYPE AND LOCATION Farzaneh Pakdel 1, Parya Emamverdizadeh
More informationAmruta Mohite 1, Anil Gugle 2*, Rahul Kote 3 and Vikrant Jadhav 4
MVP Journal of Medical Sciences, Vol 2(2), 76-80, July-December 2015 A Comparative Study of Efficacy, Safety and Relapse Rate of Three Drugs; Systemic Ketoconazole, Systemic Itraconazole and Topical Oxiconazole
More informationA Study of the Effects of CO2 Laser Therapy on Oral Lichen Planus (OLP)
2015, TextRoad Publication ISSN: 2090-4274 Journal of Applied Environmental and Biological Sciences www.textroad.com A Study of the Effects of CO2 Laser Therapy on Oral Lichen Planus (OLP) Hamidreza Mozafari
More informationOriginal Article. Direct Immunofluorescence in Clinically Diagnosed Oral Lichen Planus
JOMP Journal of Oral Medicine and Pain Original Article pissn 2288-9272 eissn 2383-8493 J Oral Med Pain 2016;41(1):16-20 http://dx.doi.org/10.14476/jomp.2016.41.1.16 Direct Immunofluorescence in Clinically
More informationDuring the last 20 years, the number of topical
THERAPEUTICS FOR THE CLINICIAN Cumulative Irritation Potential of Adapalene 0.1% Cream and Gel Compared With Tretinoin Microsphere 0.04% and 0.1% Jonathan S. Dosik, MD; Kenneth Homer, MS; Stéphanie Arsonnaud
More informationDermatology Pearls and News Flash ACP Utah Chapter Scientific Meeting 2017
Dermatology Pearls and News Flash ACP Utah Chapter Scientific Meeting 2017 Christopher M Hull, MD University of Utah School of Medicine Christopher.hull@hsc.utah.edu Conflict of interest No conflicts to
More informationThe legally binding text is the original French version
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 31 January 2007 BUCCOBET 0.1 mg, oromucosal tablet B/50 (CIP: 3741470 ) Applicant: DB PHARMA Betamethasone valerate
More informationThe Prevention and Management of Acute Skin Reactions Related to Radiation Therapy
Evidence-Based Series 13-7 IN REVIEW A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) The Prevention and Management of Acute Skin Reactions Related to Radiation
More informationVitiligo is a skin depigmentation disorder
THERPEUTICS FOR THE CLINICIN Tacrolimus Ointment 0.1% Produces Repigmentation in Patients With Vitiligo: Results of a Prospective Patient Series Emil. Tanghetti, MD The cause of the selective melanocyte
More informationRecurrent Aphthous Stomatitis: Therapeutic Management from Topicals to Systemics
REVIEW ARTICLE Recurrent Aphthous Stomatitis: Therapeutic Management from Topicals to Systemics Nidhi Puri 1, Jaskirat Kaur Gill 2, Harmandeep Kaur 2, Navdeep Kaur 2, Jaskirat Kaur 2 1 Senior lecturer,
More information12.1 DRUGS ACTING ON THE EAR
12.1 DRUGS ACTING ON THE EAR Anti-inflammatory/anti-infective preparations These preparations usually contain a corticosteroid either alone or with an antibacterial agent. Betamethasone 0.1% ear, eye,
More informationDisclaimers. Topical Therapy. The Problem. Topical Therapy for Chronic Rhinosinusitis No Disclosures
Topical Therapy for Chronic Rhinosinusitis No Disclosures Disclaimers Off-label use of multiple steroid and antibiotic medications Large talk, limited time Steven D. Pletcher MD University of California,
More informationStrengthening the teeth and decreasing the effects of acid and bacteria on the teeth. Sodium Fluoride
Dento plus mouthwash has a powerful formula that ensures the full coverage for all types of dental infections. Dento plus mouthwash adds to its formula the power of natural analgesics, natural anti inflammatory,
More information3. Acyclovir 5% ointment with Dyclonine HCl 1% or Lidocaine 1% Compound Sig: Apply to affected area q2h (start applying prodromal stage)
Cincinnati Dental Association Great Cases with New Faces November 17, 2010 THERAPEUTIC REGIMENS FOR SELECTED ORAL MUCOSAL DISEASES John A. Svirsky, DDS, MEd Virginia Commonwealth University (804) 828-0547
More informationComparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: A randomized clinical trial
Received: 10.7.2011 Accepted: 5.12.2011 Original Article Comparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: A randomized clinical trial Fariba Iraji, 1
More informationOriginal Article Clinical effect of initial periodontal therapy combined with topical medication therapy on erosive oral lichen planus
Int J Clin Exp Med 2018;11(7):7346-7351 www.ijcem.com /ISSN:1940-5901/IJCEM0077131 Original Article Clinical effect of initial periodontal therapy combined with topical medication therapy on erosive oral
More informationClinical efficacy of allicin A novel alternative therapeutic agent in the management of minor recurrent aphthous stomatitis
Journal of Advanced Clinical & Research Insights (2015), 2, 231 236 ORIGINAL ARTICLE Clinical efficacy of allicin A novel alternative therapeutic agent in the management of minor recurrent aphthous stomatitis
More informationCase Report. Pyostomatitis vegetans Knapp N et al
Received: 15 th August 2015 Accepted: 17 th November 2015 Conflicts of Interest: None Source of Support: Nil Case Report Pyostomatitis Vegetans in Ulcerative Colitis; Management with Topical Tacrolimus
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationKarnataka, India. Karnataka, India
10.5005/jp-journals-10011-1083 G RESERCH Roopashri et RTICLE al Efficacy of enzydamine Hydrochloride, Chlorhexidine and Povidone Iodine in Treatment of Oral Mucositis among Patients Undergoing Radiotherapy
More informationTexas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)
Diagnosis: ATOPIC DERMATITIS (AD) Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD) PATIENT ADVICE: Unfortunately, there is no cure for atopic dermatitis, so
More informationMethylene Blue-Mediated Photodynamic Therapy: A Possible Alternative Treatment for Oral Lichen Planus
Lasers in Surgery and Medicine 38:33 38 (2006) Methylene Blue-Mediated Photodynamic Therapy: A Possible Alternative Treatment for Oral Lichen Planus Farzane Aghahosseini, DDS, MSc, 1 Fateme Arbabi-Kalati,
More informationDr. Saeed A-Latteef A- kareem 1, Dr. Khadija M Ahmed 1
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 10 Ver. V (Oct. 2015), PP 80-84 www.iosrjournals.org Prevalence of Aphthous Ulceration in patients
More informationA case of rosacea fulminans in a pregnant woman
Hong Kong J. Dermatol. Venereol. (2018) 26, 122-126 Views and Practice A case of rosacea fulminans in a pregnant woman JE Seol, SH Park, JU Kim, GJ Cho, SH Moon, H Kim Introduction Rosacea fulminans (RF)
More informationLocation of study report in Regulatory Dossier for authorities
This document has been downloaded from www.leo-pharma.com subject to the terms of use state on the website. It contains data and results regarding approved and non-approved uses, formulations or treatment
More informationSYMPTOMATIC ORAL LICHEN
OBSERVATION Response of Oral Lichen Planus to Topical Tacrolimus in 37 Patients Julie A. Byrd, MD; Mark D. P. Davis, MD; Alison J. Bruce, MD; Lisa A. Drage, MD; Roy S. Rogers III, MD Background: Topical
More information